Quercetin as a cancer chemopreventive or chemotherapeutic agent: Where we stand
Phytotherapy Research · 2023-04 · 37 (4) · 1227-1231
DOI: 10.1002/ptr.7699 ↗At a glance
Leserbrief in Phytotherapy Research, published online on 2022-11-28. Written by Alberto Boretti. Institution: Johnsonville, Wellington, New Zealand. Major MEDLINE topics: Quercetin, Neoplasms. Cited 12 times so far (Crossref); 78 references.
Abstract (original language)
Quercetin has a wide range of potential health benefits, working as a direct or indirect agent or an adjuvant following different principles. It may be used as a generally useful or exclusive supplement, but also specifically used to treat an acute or chronic condition. Quercetin may work as a cancer chemopreventive and chemotherapeutic agent, because this versatile substance, which owns antioxidant and anti‐inflammatory properties, may also kill cancer cells and also holds senolytic properties. While both the specific chemo‐preventive or chemotherapeutic uses as a drug need clinical trials, it may be used without any contraindication as a general chemo‐preventive supplement.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Johnsonville, Wellington, New Zealand.
ORCID profiles: Alberto Boretti
Cite
APA
Boretti, A. (2023). Quercetin as a cancer chemopreventive or chemotherapeutic agent: Where we stand. Phytotherapy Research, 37(4), 1227-1231. https://doi.org/10.1002/ptr.7699
Vancouver
Boretti A. Quercetin as a cancer chemopreventive or chemotherapeutic agent: Where we stand. Phytotherapy Research. 2023;37(4):1227-1231. doi:10.1002/ptr.7699
BibTeX
@article{Boretti2023,
author = {Boretti, Alberto},
title = {Quercetin as a cancer chemopreventive or chemotherapeutic agent: Where we stand},
journal = {Phytotherapy Research},
year = {2023},
volume = {37},
number = {4},
pages = {1227--1231},
doi = {10.1002/ptr.7699}
}
EUVIMED